April 1, 2024

Dan Albertson, MD, will serve as president of the new University Business Unit and become a member of ARUP’s executive committee. Albertson said service to patients and colleagues will be his focus.

March 21, 2024

The FDA’s proposed rule to regulate lab-developed tests will force labs to halt essential testing, harming children and patients with cancer and rare diseases, says ARUP’s Jonathan Genzen, MD, PhD.

March 15, 2024

Of the ARUP clients who participated in the 2023 client satisfaction survey, 93% had a favorable impression of the company, up from 91% in 2022.

March 5, 2024

Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to

February 29, 2024

February is American Heart Month, and ARUP Consult has current resources on testing for acute coronary syndrome, heart failure, and atherosclerotic cardiovascular disease markers.

February 5, 2024

Researchers at ARUP Laboratories published more than 130 peer-reviewed articles and contributed more than 135 posters or presentations at medical conferences in FY2023 to advance laboratory medicine.

January 16, 2024

Lab testing is key to thyroid disease diagnosis and proper treatment but can be challenging. ARUP Consult’s thyroid disease testing resources are divided into easy-to-navigate topics and algorithms.